Strides Pharma Science Limited (BOM:532531)
India · Delayed Price · Currency is INR 1,027.35
-53.45 (-4.95%)
At close: Jun 4, 2026
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 96.28 billion as of June 5, 2026. Its market cap has increased by 57.94% in one year.
Market Cap
96.28B
Enterprise Value
112.15B
Revenue
48.59B
Ranking
n/a
PE Ratio
17.31
Stock Price
1,027.35
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 96.28B, an increase of 1,184.82%. That is a compound annual growth rate of 10.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 96.28B | 16.02% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 214.97B |
| Rubicon Research | 198.11B |
| Granules India | 195.66B |
| Jubilant Pharmova | 153.61B |
| Caplin Point Laboratories | 153.14B |
| Viyash Scientific | 108.77B |
| CORONA Remedies | 105.50B |
| Procter & Gamble Health | 102.46B |